Anyone who’s spent any time at all on the Mental Elf website, or any of the other National Elf Service sites, knows that we elves love succinct and focused summaries that are easy to read and quick to digest. It’s always a delight to see other groups publishing similar resources, so I’ve decided today to [read the full story…]
The reduced life expectancy (15-20 years less) often faced by many people with schizophrenia is frequently a result of cardiovascular disease. Lifestyle choices (smoking, lack of exercise and poor diet) can increase the risk of these diseases, but people who take antipsychotic drugs often have the additional problem of weight gain that is caused by [read the full story…]
Regular readers of the Mental Elf will recall the blogs (Here is the evidence for exercising if you are depressed and New Cochrane review shows that exercise helps with depression) I wrote back in June and July about the evidence for exercising if you have depression. A new systematic review was published in the British [read the full story…]
Weight gain is one of the side effects that people who take antipsychotic drugs complain of the most. Obesity is common in this population and this can often lead to cardiovascular problems and a far shorter life expectancy than the rest of the population. As a result, there is a great deal of interest in [read the full story…]
Another week, another new type of publication from NICE. The local government public health briefings are aimed at local authorities and their partner organisations in the health and voluntary sectors, in particular those involved with health and wellbeing boards. Three briefings have been launched today on: Tobacco Physical activity Workplace health These briefings will be relevant [read the full story…]
This is perfect timing from the chaps at the Cochrane Depression, Anxiety and Neurosis Group. After all the hubbub about exercise and depression a few weeks ago, it’s great to read an updated version of their systematic review that looks at the effectiveness of exercise in the treatment of depression. The review looked for randomised [read the full story…]
Ooh, what a palaver over the depression and exercise story! Such a lot of words have been written about the study published in the BMJ last week, including by me. The study itself was well conducted but frankly disappointing (for us readers and the researchers themselves), finding as it did that a specific treatment to [read the full story…]
Back from my 5-mile run around the woodland yesterday morning I sat down to catch up on the latest elf stories. Many of the national newspapers reported on a new randomised controlled trial published in the BMJ, which studied ‘facilitated physical activity’ for people with depression. The headlines seemed to be in agreement: Exercise ‘no [read the full story…]
For many different reasons, people with schizophrenia and schizoaffective disorders have a greater risk of type 2 diabetes. The prevalence of type 2 diabetes in people with schizophrenia is twice that of the general population. This review looked for evidence of the efficacy of interventions to help people with schizophrenia manage their diabetes. Clinical question [read the full story…]
Exercise is a good thing right? It seems obvious that people who are affected by mental health problems would benefit from getting themselves outside and becoming more active, but are these ‘treatments’ value for money when they are delivered in a structured way? The current NICE depression guideline recommends ‘structured’ physical activity programmes for depression [read the full story…]
